Heidelberg Pharma AG

Heidelberg Pharma AG financial statements

Heidelberg Pharma AG's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueEUR 1.46MEODHD
Net income−EUR 42.28MEODHD
Cash and equivalentsEUR 14.98MEODHD
Total debtEUR 1.16MEODHD

Heidelberg Pharma AG financials on 6ix · Heidelberg Pharma AG on 6ix